Linn F H, Rinkel G J, Algra A, van Gijn J
University Department of Neurology, Utrecht, Netherlands.
Stroke. 1996 Apr;27(4):625-9. doi: 10.1161/01.str.27.4.625.
The incidence of subarachnoid hemorrhage (SAH) has been estimated for many years at 10 to 15 per 100 000 person-years, but the most recent studies yield lower figures, of 6 to 8 per 100 000 person-years. To investigate the cause of this apparent decline, we studied the influence of year to study, rate of CT,and region.
Eighteen studies fulfilled predefined inclusion criteria. In three Finnish studies, the pooled incidence was 21.4 per 100 000 person-years (95% confidence interval [CI], 19.5 to 23.4); in 15 non-Finnish studies, it was 7.8 per 100 000 person-years (95% CI, 7.2 to 8.4). With univariate analysis, in non-Finnish studies the incidence decreased .96% for each percentage point increase of patients investigated with CT (rate ratio, -0.9904; 95% CI, 0.9878 to 0.9930). With 100% CT scanning, the incidence of SAH outside Finland is estimated at 6 per 100 000 person-years. The rate ratio for year of study was 0.952 (95% CI, 0.935 to 0.969) for each later year in the period 1960 to 1994. In multivariate analysis, only the use of CT was independently related to SAH incidence. For the Finnish studies, the rate ratios for use of CT and year to study were not statistically significant. We also found in six studies that incidence for women was 1.6 (95% CI, 1.1 to 2.3) times higher than that for men (7.1 [95% CI, 5.4 to 8.7] and 4.5 [95% CI, 3.1 to 5.8], respectively).
The actual incidence of SAH has remained stable over the last three decades; the apparent decline in incidence is entirely explained by the greater proportion of patients investigated with CT. The incidence of SAH in Finland is almost three times as high as in other parts of the world.
多年来蛛网膜下腔出血(SAH)的发病率估计为每10万人年10至15例,但最近的研究得出的数字较低,为每10万人年6至8例。为了调查这种明显下降的原因,我们研究了研究年份、CT使用率和地区的影响。
18项研究符合预先设定的纳入标准。在三项芬兰研究中,合并发病率为每10万人年21.4例(95%置信区间[CI],19.5至23.4);在15项非芬兰研究中,为每10万人年7.8例(95%CI,7.2至8.4)。单因素分析显示,在非芬兰研究中,CT检查患者比例每增加一个百分点,发病率下降0.96%(率比,-0.9904;95%CI,0.9878至0.9930)。若CT扫描率为100%,芬兰以外地区SAH的发病率估计为每10万人年6例。在1960年至1994年期间,每往后一年,研究年份的率比为0.952(95%CI,0.935至0.969)。多因素分析显示,只有CT的使用与SAH发病率独立相关。对于芬兰的研究,CT使用和研究年份的率比无统计学意义。我们还在六项研究中发现,女性的发病率是男性的1.6倍(95%CI,1.1至2.3)(分别为7.1[95%CI,5.4至8.7]和4.5[95%CI,3.1至5.8])。
在过去三十年中,SAH的实际发病率保持稳定;发病率的明显下降完全是由接受CT检查的患者比例增加所致。芬兰SAH的发病率几乎是世界其他地区的三倍。